FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称VALANCITUG
异名/同义词H-GAMMA1 HEAVY CHAIN HUMANIZED (1-453) (VH (HOMO SAPIENS IGHV3-30*02 (75.8%) -(IGHD) -IGHJ4*01 (93.3%), CDR-IMGT (8.9.16) (26-33.51-59.97-112)) (1-123) -HOMO SAPIENS IGHG1*03V (100%) G1M3>G1M17, NG1M1 CH1 K120, CH3 E12, M14 (CH1 R120>K(220) (124-221), HINGE 1-15 (222-236), CH2 (237-346), CH3 E12 (362), M14 (364) (347-451), CHS (452-453)) (124-453)), (226-214')-DISULFIDE WITH L-KAPPA LIGHT CHAIN HUMANIZED (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-16*01 (87.4%) -IGKJ1*01 (100%), CDR-IMGT (6.3.9) (27'-32'.50'-52'.89'-97')) (1'-107') -HOMO SAPIENS IGKC*01 (100%) KM3 A45.1, V101 (C-KAPPA A45.1 (153'), V101 (191')) (108'-214')); DIMER (232-232'':235-235'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-K1, GLYCOFORM ALFA
IMMUNOGLOBULIN G1, ANTI-(HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A) (HUMAN-MUS MUSCULUS MONOCLONAL BAT5906 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BAT5906 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS VEGFA (VASCULAR ENDOTHELIAL GROWTH FACTOR A, VEGF-A, VEGF)), HUMANIZED MONOCLONAL ANTIBODY (VALANCITUG)
VALANCITUG
VALANCITUG [INN]
CAS登记号2766342-47-4
物质唯一标识(Unique Ingredient Identifier)XWG7NS56FL
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System